80 FR 27329 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 92 (May 13, 2015)

Page Range		27329-27329
FR Document		2015-11476

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting on June 9-10, 2015. The meeting is open to the public. However, pre- registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac. Participants may also register by emailing [email protected] or by calling 202-690-5566 and providing their name, organization, and email address.

Federal Register, Volume 80 Issue 92 (Wednesday, May 13, 2015)

[Federal Register Volume 80, Number 92 (Wednesday, May 13, 2015)]
[Notices]
[Page 27329]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2015-11476]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a meeting
on June 9-10, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment.
Individuals who wish to attend the meeting and/or participate in the
public comment session should register at http://www.hhs.gov/nvpo/nvac.
Participants may also register by emailing nvpo@hhs.gov or by calling
202-690-5566 and providing their name, organization, and email address.

DATES: The meeting will be held on June 9-10, 2015. The meeting times
and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington,
DC 20201.
The meeting can also be accessed through a live webcast the day of
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S.
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone:
(202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The NVAC was established to provide advice and
make recommendations to the Director of the National Vaccine Program on
matters related to the Program's responsibilities. The Assistant
Secretary for Health serves as Director of the National Vaccine
Program.
The June NVAC meeting will include the presentation of
recommendations from several of the NVAC working groups for
deliberation and vote. The Vaccine Confidence Working Group will
present their report and recommendations for measuring and evaluating
how confidence in vaccines impacts the optimal use of recommended
childhood vaccines in the United States. Following an update on current
efforts by national stakeholders to improve Human Papilloma Virus (HPV)
vaccine uptake among adolescents, the HPV working group will also
present their report and recommendations identifying existing best
practices to increase the use of the HPV vaccine in young adolescents.
NVAC will review analyses and proposed recommendations on how vaccines
could play more prominently in efforts described in the President's
National Strategy and Action Plan to Combat Antibiotic Resistant
Bacteria.
An overview of the Vaccine Safety Research Agenda that was released
on the NVPO Web site in February 2015 will also be provided. The
Vaccine Safety Research Agenda outlines the efforts of federal agencies
on vaccine safety and the ongoing and planned associated scientific
activities and interagency coordination that contribute to the safety
system. Informational presentations will also be provided to inform
NVAC members of recent developments impacting the vaccine landscape
including Congressional efforts to support the research and development
of new vaccine products through the 21st Century Cures Initiative. More
information on the meeting agenda will be posted prior to the meeting
on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the National Vaccine Program Office at the address/phone listed
above at least one week prior to the meeting. For those unable to
attend in person, a live webcast will be available. More information on
registration and accessing the webcast can be found at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.
Members of the public will have the opportunity to provide comments
at the NVAC meeting during the public comment periods designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit their written
comments. Written comments should not exceed three pages in length.
Individuals submitting written comments should email their comments to
the National Vaccine Program Office (nvpo@hhs.gov) at least five
business days prior to the meeting.

Dated: May 4, 2015.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy
Assistant Secretary for Health, Director, National Vaccine Program
Office.
[FR Doc. 2015-11476 Filed 5-12-15; 8:45 am]
BILLING CODE 4150-44-P

Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices 27329

SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: meeting agenda will be posted prior to
Authority: 42 CFR 83.9–83.12. National Vaccine Program Office, U.S. the meeting on the NVAC Web site:
Department of Health and Human http://www.hhs.gov/nvpo/nvac.
Pursuant to 42 CFR 83.12, the initial Services, Room 715–H, Hubert H. Public attendance at the meeting is
proposed definition for the class being Humphrey Building, 200 Independence limited to the available space.
evaluated, subject to revision as Avenue SW., Washington, DC 20201. Individuals who plan to attend and
warranted by the evaluation, is as Phone: (202) 690–5566; email: nvpo@ need special assistance, such as sign
follows: hhs.gov.
Facility: Blockson Chemical language interpretation or other
Company. SUPPLEMENTARY INFORMATION: Pursuant reasonable accommodations, should
Location: Joliet, Illinois. to Section 2101 of the Public Health notify the National Vaccine Program
Job Titles and/or Job Duties: All Service Act (42 U.S.C. 300aa–1), the Office at the address/phone listed above
workers who worked in any area. Secretary of Health and Human Services at least one week prior to the meeting.
Period of Employment: July 1, 1960 was mandated to establish the National For those unable to attend in person, a
through December 31, 1991. Vaccine Program to achieve optimal live webcast will be available. More
prevention of human infectious diseases information on registration and
John Howard, accessing the webcast can be found at
through immunization and to achieve
Director, National Institute for Occupational optimal prevention against adverse http://www.hhs.gov/nvpo/nvac/
Safety and Health. meetings/upcomingmeetings/
reactions to vaccines. The NVAC was
[FR Doc. 2015–11471 Filed 5–12–15; 8:45 am] index.html.
established to provide advice and make
BILLING CODE 4163–19–P recommendations to the Director of the Members of the public will have the
National Vaccine Program on matters opportunity to provide comments at the
related to the Program’s responsibilities. NVAC meeting during the public
DEPARTMENT OF HEALTH AND The Assistant Secretary for Health comment periods designated on the
HUMAN SERVICES serves as Director of the National agenda. Public comments made during
Meeting of the National Vaccine Vaccine Program. the meeting will be limited to three
Advisory Committee The June NVAC meeting will include minutes per person to ensure time is
the presentation of recommendations allotted for all those wishing to speak.
AGENCY: National Vaccine Program from several of the NVAC working Individuals are also welcome to submit
Office, Office of the Assistant Secretary groups for deliberation and vote. The their written comments. Written
for Health, Office of the Secretary, Vaccine Confidence Working Group will comments should not exceed three
Department of Health and Human present their report and pages in length. Individuals submitting
Services. recommendations for measuring and written comments should email their
ACTION: Notice. evaluating how confidence in vaccines comments to the National Vaccine
impacts the optimal use of Program Office (nvpo@hhs.gov) at least
SUMMARY: As stipulated by the Federal recommended childhood vaccines in five business days prior to the meeting.
Advisory Committee Act, the the United States. Following an update Dated: May 4, 2015.
Department of Health and Human on current efforts by national
Services (HHS) is hereby giving notice Bruce Gellin,
stakeholders to improve Human
that the National Vaccine Advisory Executive Secretary, National Vaccine
Papilloma Virus (HPV) vaccine uptake Advisory Committee, Deputy Assistant
Committee (NVAC) will hold a meeting among adolescents, the HPV working Secretary for Health, Director, National
on June 9–10, 2015. The meeting is open group will also present their report and Vaccine Program Office.
to the public. However, pre-registration recommendations identifying existing [FR Doc. 2015–11476 Filed 5–12–15; 8:45 am]
is required for both public attendance best practices to increase the use of the BILLING CODE 4150–44–P
and public comment. Individuals who HPV vaccine in young adolescents.
wish to attend the meeting and/or NVAC will review analyses and
participate in the public comment proposed recommendations on how DEPARTMENT OF HEALTH AND
session should register at http:// vaccines could play more prominently HUMAN SERVICES
www.hhs.gov/nvpo/nvac. Participants in efforts described in the President’s
may also register by emailing nvpo@ National Strategy and Action Plan to Determination Concerning a Petition
hhs.gov or by calling 202–690–5566 and Combat Antibiotic Resistant Bacteria. To Add a Class of Employees To the
providing their name, organization, and An overview of the Vaccine Safety Special Exposure Cohort
email address. Research Agenda that was released on
DATES: The meeting will be held on June the NVPO Web site in February 2015 AGENCY: National Institute for
9–10, 2015. The meeting times and will also be provided. The Vaccine Occupational Safety and Health
agenda will be posted on the NVAC Safety Research Agenda outlines the (NIOSH), Centers for Disease Control
Web site at http://www.hhs.gov/nvpo/ efforts of federal agencies on vaccine and Prevention, Department of Health
nvac as soon as they become available. safety and the ongoing and planned and Human Services (HHS).
ADDRESSES: U.S. Department of Health associated scientific activities and ACTION: Notice.
and Human Services, Hubert H. interagency coordination that contribute
Humphrey Building, Room 800, 200 to the safety system. Informational SUMMARY: HHS gives notice of a
asabaliauskas on DSK5VPTVN1PROD with NOTICES

Independence Avenue SW., presentations will also be provided to determination concerning a petition to
Washington, DC 20201. inform NVAC members of recent add a class of employees from the St.
The meeting can also be accessed developments impacting the vaccine Louis Airport Storage Site (SLAPS) in
through a live webcast the day of the landscape including Congressional St. Louis, Missouri, to the Special
meeting. For more information, visit efforts to support the research and Exposure Cohort (SEC) under the Energy
http://www.hhs.gov/nvpo/nvac/ development of new vaccine products Employees Occupational Illness
meetings/upcomingmeetings/ through the 21st Century Cures Compensation Program Act of 2000
index.html. Initiative. More information on the (EEOICPA).

VerDate Sep<11>2014 17:27 May 12, 2015 Jkt 235001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\13MYN1.SGM 13MYN1

Document Created: 2015-12-16 07:47:09
Document Modified: 2015-12-16 07:47:09

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting will be held on June 9-10, 2015. The meeting times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/ nvpo/nvac as soon as they become available.
Contact		National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715-H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		80 FR 27329